{"id":38793,"date":"2018-01-13T23:29:00","date_gmt":"2018-01-14T03:29:00","guid":{"rendered":"http:\/\/blogs.sld.cu\/marionod\/?p=38793"},"modified":"2018-01-13T23:29:00","modified_gmt":"2018-01-14T03:29:00","slug":"journal-of-immunotherapy-and-precision-oncology","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/marionod\/2018\/01\/13\/journal-of-immunotherapy-and-precision-oncology\/","title":{"rendered":"Journal of Immunotherapy and Precision Oncology"},"content":{"rendered":"<p><a href=\"http:\/\/www.jipoonline.org\/\" target=\"_blank\">Journal of Immunotherapy and Precision Oncology<\/a><\/p>\n<p>Revista a texto completo y arbitrada quarterly de la editorial Medknow publication of Global Academy of Health Sciences <span id=\"result_box\" class=\"\" lang=\"es\"><span title=\"JIPO aims to publish high-quality manuscripts related to the field of immunotherapy and precision oncology.\">que\u00a0 tiene como objetivo publicar manuscritos de alta calidad relacionados con el campo de la inmunoterapia y la oncolog\u00eda de precisi\u00f3n. <\/span><span title=\"The content will appeal to a broad readership of healthcare professionals and scientists, especially those with an interest in oncology and immunology.\">El contenido atraer\u00e1 a un amplio p\u00fablico de profesionales de la salud y cient\u00edficos, especialmente aquellos con inter\u00e9s en oncolog\u00eda e inmunolog\u00eda. <\/span><span title=\"There will be innovative original articles including translational science and clinical medicine, review articles, editorials, controversy, and others.\n\n\">Habr\u00e1 art\u00edculos originales innovadores que incluyen ciencia traslacional y medicina cl\u00ednica, art\u00edculos de revisi\u00f3n, editoriales, controversia y otros.<br \/>\n<\/span><span title=\"Manuscripts related to clinical and translational discoveries related with immunity and cancer and immunotherapy, such as new discoveries about immune system function and biology, new therapeutic approaches to different malignancies, mechanisms of resistance, clinical assessment, and more will be considered for publication.\">Se considerar\u00e1n para su publicaci\u00f3n los manuscritos relacionados con descubrimientos cl\u00ednicos y traslacionales relacionados con inmunidad y c\u00e1ncer e inmunoterapia, como nuevos descubrimientos sobre la funci\u00f3n y biolog\u00eda del sistema inmune, nuevos enfoques terap\u00e9uticos para diferentes tumores malignos, mecanismos de resistencia, evaluaci\u00f3n cl\u00ednica y m\u00e1s. <\/span><span title=\"Subjects related to precision oncology including prognostic or predictive markers and innovative targeted therapy advances in diagnostic technology will also be considered.\n\n\">Tambi\u00e9n se considerar\u00e1n los temas relacionados con la oncolog\u00eda de precisi\u00f3n, incluidos los marcadores pron\u00f3sticos o predictivos y los innovadores avances terap\u00e9uticos dirigidos en la tecnolog\u00eda de diagn\u00f3stico.<br \/>\n<\/span><span title=\"Sub-topic based Supplements may be published.\">Los suplementos basados \u200b\u200ben subtemas pueden publicarse. <\/span><span title=\"This allows the journal to highlight issues relevant to the Journal readers.\">Esto permite que la revista resalte los problemas relevantes para los lectores de la Revista. <\/span><span title=\"High quality evidence based guidelines of credible professional entities will be considered for publications.\">Se considerar\u00e1n publicaciones de alta calidad basadas en evidencia de entidades profesionales cre\u00edbles. Idioma: ingl\u00e9s<\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Journal of Immunotherapy and Precision Oncology Revista a texto completo y arbitrada quarterly de la editorial Medknow publication of Global Academy of Health Sciences que\u00a0 tiene como objetivo publicar manuscritos de alta calidad relacionados con el campo de la inmunoterapia y la oncolog\u00eda de precisi\u00f3n. El contenido atraer\u00e1 a un amplio p\u00fablico de profesionales de [&hellip;]<\/p>\n","protected":false},"author":126,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[66,485,9],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts\/38793"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/users\/126"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/comments?post=38793"}],"version-history":[{"count":1,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts\/38793\/revisions"}],"predecessor-version":[{"id":38794,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts\/38793\/revisions\/38794"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/media?parent=38793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/categories?post=38793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/tags?post=38793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}